Abstract
Human recombinant erythropoietin (EPO) was successively labeled with [111In]-indium chloride after conjugation with freshly prepared cyclic DTPA-dianhydride (ccDTPA). The best results of the conjugation were obtained by the addition of 100 i.u. of an EPO pharmaceutical solution (in phosphate buffer, pH 7.5) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25 °C with continuous mild stirring for 30 minutes. Radio thin layer chromatography (RTLC), instant thin layer chromatography (ITLC) and high performance liquid chromatography (HPLC) showed overall radiochemical purity of higher than 95% at optimized conditions (specific activity = 1.2–1.5 GBq/mg, labeling efficiency 80%). Preliminary in vivo studies in normal rat model was performed to determine the biodistribution of the radiotracer up to 1 hour using scarification. The high kidney uptake of the tracer was consistent with the reported EPO receptor distribution.
Similar content being viewed by others
References
M. J. Koury, S. T. Sawyer, S. Brandt, Curr. Opinion Hematol., 9 (2002) 93.
D. Wen, J. Boissel, T. Tracy, R. Gruninger, L. Mulcahy, J. Czelusniak, M. Goodman, H. Bunn, Blood, 82 (1993) 1507.
H. Wu, X. Liu, R. Jaenisch, H. F. Lodish, Cell, 83 (1995) 59.
C. S. Lin, S. K. Lim, V. D’Agati, F. Costantini, Genes Dev., 10 (1996) 154.
H. Wu, S. H. Lee, J. Gao, X. Liu, M. L. Iruela-Arispe, Development, 126 (1999) 3597.
M. L. Brines, P. Ghezzi, S. Keenan, Proc. Natl. Acad. Sci. USA, 97 (2000) 10526.
A. Gorio, N. Gokmen, S. Erbayraktar, Proc. Natl. Acad. Sci. USA, 99 (2002) 9450.
M. Celik, N. Gokmen, S. Erbayraktar, Proc. Natl. Acad. Sci. USA, 99 (2002) 2258.
D. Aagnello, P. Bigini, P. Villa, Brain Res., 952 (2002) 128.
R. Bianchi, B. Buyukakilli, M. Brines, Proc. Natl. Acad. Sci. USA, 101 (2004) 823.
A. L. Siren, M. Fratelli, M. Brines, Proc. Natl. Acad. Sci. USA, 98 (2001) 4044.
S. E. Juul, D. J. Ledbetter, A. E. Joyce, C. Dame, R. D. Christensen, Y. Zhao, V. DeMarco, Gut, 49 (2001) 182.
A. L. Miller-Gilbert, S. H. Dubuque, B. Dvorak, C. S. Williams, J. G. Grille, S. S. Woodward, O. Koldovsky, P. J. Kling, Pediatr. Res., 50 (2001) 261.
J. A. Widness, R. L. Schmidt, P. Veng-Pedersen, N. B. Modi, S. T. Sawyer, J. Lab. Clin. Med., 119 (1992) 285.
A. Anagnostou, E. S. Lee, N. Kessimian, R. Levinson, M. Steiner, Proc. Natl. Acad. Sci. USA, 87 (1990) 5978.
A. Tojo, H. Fukamachi, T. Saito, M. Kasuga, A. Urabe, F. Takaku, Cancer Res., 48 (1988) 1818.
Y. Yasuda, Y. Fujita, T. Matsuo, Carcinogenesis, 24 (2003) 2.
M. O. Arcasoy, K. Amin, A. F. Karayal, Lab. Invest., 82 (2002) 9.
C. Westenfelder, R. L. Baranowski, Kidney Intern., 58 (2000) 647.
Y. Yasuda, Y. Fujita, S. Masuda, Carcinogenesis, 23 (2002) 797.
Z. Marczenko, Spectrophotometric Determination of Elements, John Wiley & Sons Inc., New York, 1976, p. 238.
Z. Marczenko, Spectrophotometric Determination of Elements, John Wiley & Sons Inc., New York, 1976, Cahpter 12, p. 176.
D. J. Hnatowich, W. W. Layne, R. L. Child, Science, 220 (1983) 613.
W. C. Eckelman, S. M. Karesh, R. C. Reba, J. Pharm. Sci., 64 (1975) 704.
M. A. Green, M. J. Welch, Nucl. Med. Biol., 16 (1989) 435.
http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&id=312304
P. Kokhael, A. O. Abdalla, L. Hansson, E. Mikaelsson, M. Kubbies, A. Haselbeck, H. Jernberg-Wiklund, H. KanMellstedt, A. Osterborg, Clin. Cancer Res., 13 (2007) 3536.
E. J. Sharples, N. Patel, P. Brown, J. Am. Soc. Nephrol., 15 (2004) 2115.
C. W. Yang, C. Li, J. Y. Jung, FASEB J, 17 (2003) 1754.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sadeghpour, H., Jalilian, A.R., Akhlaghi, M. et al. Preparation and biodistribution of [111In]-rHuEpo for erythropoietin receptor imaging. J Radioanal Nucl Chem 278, 117–122 (2008). https://doi.org/10.1007/s10967-007-7212-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-007-7212-1